(Q3)Dec 31, 2023 | (Q2)Sep 30, 2023 | (Q1)Jun 30, 2023 | (FY)Mar 31, 2023 | (Q2)Sep 30, 2022 | (Q1)Jun 30, 2022 | (FY)Mar 31, 2022 | (FY)Mar 31, 2021 | |
---|---|---|---|---|---|---|---|---|
Operating Cash Flow (Indirect Method) | ||||||||
Cash flow from continuing operating activities | 501.09%5.16M | 409.77%2.14M | -112.68%-714.44K | -1.29M | -690.85K | 130.81%5.63M | 2.44M | |
Net income from continuing operations | ---- | 429.82%1.99M | -140.16%-186.85K | -200.49%-2.21M | ---604.31K | --465.28K | 207.93%2.2M | --714.98K |
Depreciation and amortization | ---- | 9.19%529.09K | 15.40%499.05K | 1.30%1.87M | --484.54K | --432.44K | 58.62%1.85M | --1.16M |
Asset impairment expenditure | ---- | 157.27%773.19K | 0.00%1.35M | -47.67%1.35M | ---1.35M | --1.35M | --2.58M | ---- |
Remuneration paid in stock | ---- | --121.59K | --417.15K | -9.25%1.72M | --0 | --0 | --1.9M | --0 |
Deferred tax | ---- | --0 | ---483.01K | -182.42%-1.47M | --0 | --0 | 555.14%1.78M | --272.01K |
Other non cashItems | ---- | -192.23%-306.3K | 80.51%2.4M | 219.05%2.68M | --332.11K | --1.33M | -508.44%-2.25M | --550.65K |
Change In working capital | ---- | 1,438.02%1.99M | 56.55%-1.85M | -91.95%-4.65M | ---148.44K | ---4.27M | -828.00%-2.42M | ---261.23K |
-Change in receivables | ---- | 619.81%5.5M | -225.79%-2.44M | 87.26%-658.89K | ---1.06M | ---749.97K | -182.09%-5.17M | ---1.83M |
-Change in inventory | ---- | 124.84%523.72K | 16.52%-3.27M | 17.06%-11.93M | ---2.11M | ---3.92M | -329.89%-14.38M | ---3.35M |
-Change in prepaid assets | ---- | -262.01%-478.85K | 60.80%-115.7K | -51.63%-185.11K | --295.57K | ---295.17K | -3,809.51%-122.08K | --3.29K |
-Change in payables and accrued expense | ---- | -588.92%-4.4M | 330.06%3.11M | -61.66%1.75M | --899.04K | ---1.35M | 55.82%4.55M | --2.92M |
-Change in other current assets | ---- | -54.11%836.82K | -57.44%873.28K | -49.82%6.37M | --1.82M | --2.05M | 407.40%12.7M | --2.5M |
-Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---509.91K |
Cash from discontinued investing activities | ||||||||
Operating cash flow | --10.08M | 501.09%5.16M | 409.77%2.14M | -112.68%-714.44K | ---1.29M | ---690.85K | 130.81%5.63M | --2.44M |
Investing cash flow | ||||||||
Cash flow from continuing investing activities | 174.55%481.1K | -40.90%-318.85K | 74.12%-947.09K | -645.34K | -226.29K | -159.22%-3.66M | -1.41M | |
Net PPE purchase and sale | ---- | -234.02%-474.24K | -40.90%-318.85K | 78.98%-474.93K | ---141.98K | ---226.29K | -60.04%-2.26M | ---1.41M |
Net other investing changes | ---- | ---- | ---- | 66.27%-472.16K | ---- | ---- | ---1.4M | ---- |
Cash from discontinued investing activities | ||||||||
Investing cash flow | ---1.77M | 174.55%481.1K | -40.90%-318.85K | 74.12%-947.09K | ---645.34K | ---226.29K | -159.22%-3.66M | ---1.41M |
Financing cash flow | ||||||||
Cash flow from continuing financing activities | -279.39%-3.35M | -208.24%-1.29M | 198.70%1.63M | 1.87M | 1.19M | -39.51%-1.65M | -1.18M | |
Net issuance payments of debt | ---- | -278.41%-3.33M | -208.24%-1.29M | 198.70%1.63M | --1.87M | --1.19M | -39.51%-1.65M | ---1.18M |
Cash from discontinued financing activities | ||||||||
Financing cash flow | ---7.69M | -279.39%-3.35M | -208.24%-1.29M | 198.70%1.63M | --1.87M | --1.19M | -39.51%-1.65M | ---1.18M |
Net cash flow | ||||||||
Beginning cash position | ---- | 29.64%967.54K | -7.01%437.55K | 224.40%470.56K | --746.33K | --470.56K | -51.35%145.05K | --298.18K |
Current changes in cash | ---- | 3,647.76%2.29M | 92.18%529.99K | -110.14%-33.01K | ---64.57K | --275.77K | 312.57%325.51K | ---153.13K |
End cash Position | ---- | 377.92%3.26M | 29.64%967.54K | -7.01%437.55K | --681.77K | --746.33K | 224.40%470.56K | --145.05K |
Free cash from | --10.08M | 424.64%4.64M | 298.57%1.82M | -138.48%-1.29M | ---1.43M | ---917.14K | 224.45%3.34M | --1.03M |
Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.